NCT05745805 Cohort Follow-up of Epidemic and Neuroimaging for Patients During the 1st Wave of the COVID-19 in China
| NCT ID | NCT05745805 |
| Status | Recruiting |
| Phase | — |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University |
| Condition | COVID-19 |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2023-01-12 |
| Primary Completion | 2026-06-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2023-01-12 with a primary completion date of 2026-06-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our main objective is to analyze the development of physical impact, mental health and blood profile over follow-up time during the 1st wave of the COVID-19. Besides, we aim to establish a database of post-COVID-19 based on simultaneous cortico-spinal magnetic resonance imaging data to identify high-risk patients with long COVID and prevent the neurological symptoms evolution, optimize the tactics of management in China.
Eligibility Criteria
Inclusion Criteria: Confirmed diagnosis of mild Covid-19 (WHO criteria)/Confirmed diagnosis of moderate Covid-19 (WHO criteria)/Healthy people who have not had COVID-19 Exclusion Criteria: History of central nervous system diseases, such as mental disorder, degenerative diseases of central nervous system, tumors, trauma, etc. Participants with indication for MRI studies
Contact & Investigator
Ming Zhang, PhD
PRINCIPAL INVESTIGATOR
First Affiliated Hospital of Xian Jiaotong University
Frequently Asked Questions
Who can join the NCT05745805 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying COVID-19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05745805 currently recruiting?
Yes, NCT05745805 is actively recruiting participants. Contact the research team at zmmri@163.com for enrollment information.
Where is the NCT05745805 trial being conducted?
This trial is being conducted at Xi'an, China.
Who is sponsoring the NCT05745805 clinical trial?
NCT05745805 is sponsored by First Affiliated Hospital Xi'an Jiaotong University. The principal investigator is Ming Zhang, PhD at First Affiliated Hospital of Xian Jiaotong University. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.